IG 271 1.25mg (Ramipril 1.25 mg)
Pill with imprint IG 271 1.25mg is Yellow, Capsule-shape and has been identified as Ramipril 1.25 mg. It is supplied by InvaGen Pharmaceuticals, Inc..
Ramipril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; cardiovascular risk reduction; heart failure (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 1.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for IG 271 1.25mg
- IG 271 1.25mg
- 1.25 mg
- Prescription only
- Drug Class:
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- InvaGen Pharmaceuticals, Inc.
- Inactive Ingredients:
- pregelatinized starch
D&C Yellow No. 10
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
More about ramipril
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 63 Reviews – Add your own review/rating
- Drug class: Angiotensin Converting Enzyme Inhibitors
Other brands: Altace
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.